Fatigue in male lymphoma survivors differs between diagnostic groups and is associated with latent hypothyroidism

Acta Oncologica

Volumn 54, Issue 1, 2015, Pages 49-59

  Kiserud, Cecilie E ^a   Seland, Mette ^a   Holte, Harald ^a   Fosså, Alexander ^a   Fosså, Sophie D ^a   Bollerslev, Jens ^a   Bjoro, Trine ^a,b   Loge, Jon Håvard ^a,c  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; FOLLITROPIN; LUTEINIZING HORMONE; SEX HORMONE; TESTOSTERONE; THYROID HORMONE; THYROTROPIN;

ADULT; AGED; ARTICLE; BURKITT LYMPHOMA; CANCER CHEMOTHERAPY; CANCER FATIGUE; CANCER RADIOTHERAPY; CANCER SURVIVOR; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; FOLLOW UP; GONAD FUNCTION; HODGKIN DISEASE; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; HYPOGONADISM; HYPOTHYROIDISM; LARGE CELL LYMPHOMA; LYMPHOBLASTOMA; MAJOR CLINICAL STUDY; MALE; MANTLE CELL LYMPHOMA; MULTIMODALITY CANCER THERAPY; NONHODGKIN LYMPHOMA; PREVALENCE; QUALITY OF LIFE; T CELL LYMPHOMA; THYROID FUNCTION; THYROID HORMONE BLOOD LEVEL; AGE DISTRIBUTION; BLOOD; CHRONIC DISEASE; COMPLICATION; DAILY LIFE ACTIVITY; FATIGUE; MENTAL STRESS; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; NORWAY; QUESTIONNAIRE; SURVIVOR; VERY ELDERLY; WORK; YOUNG ADULT;

ACTIVITIES OF DAILY LIVING; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; CHRONIC DISEASE; CROSS-SECTIONAL STUDIES; FATIGUE; FOLLICLE STIMULATING HORMONE; HODGKIN DISEASE; HUMANS; HYPOGONADISM; HYPOTHYROIDISM; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NORWAY; PREVALENCE; QUALITY OF LIFE; STRESS, PSYCHOLOGICAL; SURVEYS AND QUESTIONNAIRES; SURVIVORS; THYROTROPIN; WORK; YOUNG ADULT;

EID: 84919623572     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.3109/0284186X.2014.948057     Document Type: Article

References (37)

1. Ganz PA, Bower JE. Cancer related fatigue: A focus on breast cancer and hodgkin's disease survivors. Acta Oncol 2007;46:474-9
2. Loge JH, Abrahamsen A. F, Ekeberg O, Kaasa S. Hodgkin's disease survivors more fatigued than the general population. J Clin Oncol 1999;17:253-61
3. Daniels LA, Oerlemans S, Krol A. D, van de Poll-Franse LV, Creutzberg CL. Persisting fatigue in hodgkin lymphoma survivors: A systematic review. Ann Hematol 2013;92:1023-32
4. C halder T, Berelowitz G, Pawlikowska T, Watts L, Wessely S, Wright D, et al. Development of a fatigue scale. J Psychosom Res 1993;37:147-53
5. Hjermstad M. J, Fossa S. D, Oldervoll L, Holte H, Jacobsen AB, Loge JH. Fatigue in long-term Hodgkins Disease survivors: A follow-up study. J Clin Oncol 2005;23:6587-95
6. Jensen RE, Arora NK, Bellizzi KM, Rowland JH, Hamilton AS, Aziz NM, et al. Health-related quality of life among survivors of aggressive non-Hodgkin lymphoma. Cancer 2013;119:672-80
7. Oerlemans S, Mols F, Issa DE, Pruijt JF, Peters WG, Lybeert M, et al. A high level of fatigue among (long-term] non-Hodgkin lymphoma survivors: Results from the longitudinal population-based PROFILES registry in the south of the Netherlands. Haematologica 2013;98:479-86
8. Loge JH, Abrahamsen A. F, Ekeberg, Kaasa S. F atigue and psychiatric morbidity among hodgkins disease survivors. J Pain Symptom Manage 2000;19:91-9
9. Ng AK, Li S, Recklitis C, Neuberg D, Chakrabarti S, Silver B, et al. A comparison between long-term survivors of hodgkins disease and their siblings on fatigue level and factors predicting for increased fatigue. Ann Oncol 2005;16:1949-55
10. Knobel H, Loge J. H, Lund M. B, Forfang K, Nome O, Kaasa S. Late medical complications and fatigue in hodgkins disease survivors. J Clin Oncol 2001;19:3226-33
11. G reenfi eld DM, Walters SJ, Coleman RE, Hancock BW, Snowden JA, Shalet SM, et al. Quality of life, self-esteem, fatigue, and sexual function in young men after cancer. Cancer 2010;116:1592-601
12. Howell SJ, Radford JA, Smets EM, Shalet SM. Fatigue, sexual function and mood following treatment for haematological malignancy: The impact of mild Leydig cell dysfunction. Br J Cancer 2000;82:789-93
13. Khimani N, Chen YH, Mauch PM, Recklitis C, Diller L, Silver B, et al. Influence of new late effects on quality of life over time in hodgkin lymphoma survivors: A longitudinal survey study. Ann Oncol 2013;24:226-30
14. Minton O, Berger A, Barsevick A, Cramp F, Goedendorp M, Mitchell SA, et al. Cancer-related fatigue and its impact on functioning. Cancer 2013;119(Suppl 11):2124-30
15. Kiserud CE, Fossa A, Bjoro T, Holte H, Cvancarova M, Fossa SD. Gonadal function in male patients after treatment for malignant lymphomas, with emphasis on chemotherapy. Br J Cancer 2009;100:455-63
16. Kiserud C. E, Schover L. R, Dahl AA, Fossa A, Bjoro T, Loge JH, et al. Do male lymphoma survivors have impaired sexual function?. J Clin Oncol 2009;27:6019-26
17. Zigmond A. S, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983;67:361-70
18. Ware JE, Jr. S F-36 health survey update. Spine 2000; 2 5: 3130-9
19. Bjoro T, Holmen J, Kruger O, Midthjell K, Hunstad K, Schreiner T, et al. Prevalence of thyroid disease, thyroid dysfunction and thyroid peroxidase antibodies in a large, unselected population. The Health Study of Nord-Trondelag (HUNT). Eur J Endocrinol 2000;143:639-47
20. Bjerner J, Biernat D, Fosså SD, Bj ør o. T. R eference intervals for serum testosterone, SHBG, LH and FSH in males from the NORIP project. Scand J Clin Lab Invest 2009;0:1-7
21. Reinertsen K. V, Cvancarova M, Loge J. H, Edvardsen H, Wist E, Fossa SD. Predictors and course of chronic fatigue in long-term breast cancer survivors. J Cancer Surviv 2010;4:405-14
22. Joly F, Henry-Amar M, Arveux P, Reman O, Tanguy A, Peny AM, et al. Late psychosocial sequelae in hodgkins disease survivors: A French population-based case-control study. J Clin Oncol 1996;14:2444-53
23. Abrahamsen AF, Loge J. H, Hannisdal E, Nome O, Lund M. B, Holte H, et al. Late medical sequelae after therapy for supradiaphragmatic Hodgkin disease. Acta Oncol 1999;38:511-5
24. Lund M. B, Kongerud J, Boe J, Nome O, Abrahamsen AF, Ihlen H, et al. Cardiopulmonary sequelae after treatment for hodgkin disease: Increased risk in females?. Ann Oncol 1996;7:257-64
25. Singer PA, Cooper DS, Levy EG, Ladenson PW, Braverman LE, Daniels G, et al. Treatment guidelines for patients with hyperthyroidism and hypothyroidism. Standards of Care Committee, American Thyroid Association. JAMA 1995;273:808-12
26. Canaris G. J, Manowitz N. R, Mayor G, Ridgway E. C. The Colorado thyroid disease prevalence study. Arch Intern Med 2000;160:526-34
27. Grabe HJ, Volzke H, Ludemann J, Wolff B, Schwahn C, John U, et al. Mental and physical complaints in thyroid disorders in the general population. Acta Psychiatr Scand 2005;112:286-93
28. Kong WM, Sheikh MH, Lumb PJ, Naoumova RP, Freedman DB, Crook M, et al. A 6-month randomized trial of thyroxine treatment in women with mild subclinical hypothyroidism. Am J Med 2002;112:348-54
29. Haymart MR, Repplinger DJ, Leverson GE, Elson DF, Sippel RS, Jaume JC, et al. Higher serum thyroid stimulating hormone level in thyroid nodule patients is associated with greater risks of differentiated thyroid cancer and advanced tumor stage. J Clin Endocrinol Metab 2008;93:809-14
30. Vanderpump MP, Tunbridge WM, French JM, Appleton D, Bates D, Clark F, et al. The incidence of thyroid disorders in the community: A twenty-year follow-up of the Whickham Survey. Clin Endocrinol (Oxf) 1995;43:55-68
31. Y eap B. B. Testosterone and ill-health in aging men. Nat Clin Pract Endocrinol Metab 2009;5:113-21
32. Wu F. C, Tajar A, Beynon J. M, Pye S. R, Silman AJ, Finn JD, et al. Identifi cation of late-onset hypogonadism in middle-aged and elderly men. N Engl J Med 2010;363:123-35
33. Bower JE, Bak K, Berger A, Breitbart W, Escalante CP, Ganz PA, et al. Screening, assessment, and management of fatigue in adult survivors of cancer: An American Society of Clinical Oncology Clinical Practice Guideline Adaptation. J Clin Oncol Epub 2014 Apr 21
34. Hjermstad M. J, Oldervoll L, Fossa S. D, Holte H, Jacobsen AB, Loge JH. Quality of life in long-term Hodgkin disease survivors with chronic fatigue. Eur J Cancer 2006;42:327-33
35. Chen AB, Feng Y, Neuberg D, Recklitis C, Diller LR, Mauch PN, et al. Employment and insurance in survivors of hodgkin lymphoma and their siblings: A questionnaire study. Leuk Lymphoma 2012;53:1474-80
36. Syse A, Tretli S, Kravdal O. Cancer s impact on employment and earnings-a population-based study from Norway. J Cancer Surviv 2008;2:149-58
37. Spelten ER, Verbeek JH, Uitterhoeve A. L, Ansink A. C, van Der LJ, de Reijke TM, et al. Cancer, fatigue and the return of patients to work-a prospective cohort study. Eur J Cancer 2003;39:1562-7